Community Financial Services Group LLC Has $5.69 Million Stake in Zoetis Inc. (NYSE:ZTS)

Community Financial Services Group LLC grew its position in shares of Zoetis Inc. (NYSE:ZTS) by 2.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 34,566 shares of the company’s stock after buying an additional 873 shares during the quarter. Community Financial Services Group LLC’s holdings in Zoetis were worth $5,691,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in ZTS. Brighton Jones LLC lifted its holdings in shares of Zoetis by 180.4% during the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after buying an additional 2,978 shares during the last quarter. Bank Pictet & Cie Europe AG raised its stake in shares of Zoetis by 5.4% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 419,530 shares of the company’s stock valued at $68,354,000 after acquiring an additional 21,470 shares in the last quarter. Sigma Planning Corp raised its stake in shares of Zoetis by 4.3% in the 4th quarter. Sigma Planning Corp now owns 3,367 shares of the company’s stock valued at $549,000 after acquiring an additional 140 shares in the last quarter. Howard Capital Management Inc. raised its stake in shares of Zoetis by 9.6% in the 4th quarter. Howard Capital Management Inc. now owns 3,163 shares of the company’s stock valued at $515,000 after acquiring an additional 277 shares in the last quarter. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund raised its stake in shares of Zoetis by 13.4% in the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 101,811 shares of the company’s stock valued at $16,588,000 after acquiring an additional 12,000 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Roxanne Lagano sold 652 shares of the firm’s stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total transaction of $110,840.00. Following the completion of the transaction, the executive vice president now directly owns 15,129 shares of the company’s stock, valued at approximately $2,571,930. This trade represents a 4.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.16% of the company’s stock.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $157.51 on Tuesday. The company has a quick ratio of 1.04, a current ratio of 1.74 and a debt-to-equity ratio of 1.12. The business’s 50 day moving average is $159.72 and its two-hundred day moving average is $163.10. The company has a market cap of $70.13 billion, a P/E ratio of 28.28, a P/E/G ratio of 2.61 and a beta of 0.94. Zoetis Inc. has a 12 month low of $139.70 and a 12 month high of $200.33.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.40 by $0.08. The company had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $2.20 billion. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The company’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.38 EPS. On average, equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Stockholders of record on Friday, July 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date of this dividend is Friday, July 18th. Zoetis’s dividend payout ratio is 35.91%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on ZTS shares. Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Stifel Nicolaus downgraded Zoetis from a “buy” rating to a “hold” rating and cut their price objective for the company from $165.00 to $160.00 in a research note on Wednesday, June 18th. UBS Group cut their price objective on Zoetis from $189.00 to $170.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 7th. Finally, Piper Sandler raised their price objective on Zoetis from $205.00 to $210.00 and gave the company an “overweight” rating in a research note on Monday, May 12th. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $212.13.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.